Clinical Trial Update: Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan [Phase 3]

View source ↗

Summary

Pfizer conducted a Phase 3 trial in Japan to evaluate lorazepam for the treatment of status epilepticus or repetitive status epilepticus. The study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Status Epilepticus

Drugs mentioned

• Lorazepam (Lorazepam)

Snippet

Sponsor: Pfizer | Conditions: Status Epilepticus | Phase 3 | Status: COMPLETED | Results posted: 2019-02-18